Product Dossier
ZYNLONTA
Product Dossier for ZYNLONTA (loncastuximab tesirine, Swedish Orphan Biovitrum). ARTG record, PBS listing, PBAC outcomes, AusPAR — compiled by arcimedes.
- Sponsor: Swedish Orphan Biovitrum
- Active ingredient: loncastuximab tesirine
- Therapeutic area: Oncology
- Same area: TALZENNA
- Same area: ZARZIO